Ameriprise Financial »

Peregrine Pharmaceuticals shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $879k 71k 12.35
2024-09-30 $653k 57k 11.38
2024-06-30 $391k 55k 7.14
2024-03-31 $424k 63k 6.70
2023-09-30 $2.8M 297k 9.44
2023-06-30 $4.5M 324k 13.97
2023-03-31 $6.3M 335k 18.76
2022-12-31 $4.7M 342k 13.77
2022-09-30 $6.7M 351k 19.12
2022-06-30 $9.2M 602k 15.26
2022-03-31 $13M 614k 20.37
2021-12-31 $18M 604k 29.18
2021-09-30 $1.2M 56k 21.58
2021-06-30 $991k 39k 25.63
2021-03-31 $715k 39k 18.23